Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Nerve Growth Factor Market Today And What Is Its Future Size?

The market size for nerve growth factor has seen robust growth in the past few years. Forecasts predict it will move from a worth of $1.11 billion in 2024 to a value of $1.19 billion in 2025, illustrating a compound annual growth rate (CAGR) of 7.1%. The growth observed in the historic period is due to factors such as a surge in traumatic brain injuries, a rise in neurodegenerative disease prevalence, an increase in R&D investments, heightened awareness about nerve regeneration treatments, and a growing number of peripheral neuropathy cases.

Anticipations are high for the nerve growth factor market as it is set to experience robust expansion in the coming years. Projections indicate growth to reach “$1.59 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period could be as a result of the increasing need for biopharmaceuticals, a surge in the occurrence of autoimmune neurological disorders, a growing interest in neuroinflammation study, more investments flowing into AI-driven drug discovery, and a rise in consumer demand for NGF-focused therapies. Key trends expected during the forecast period are advancements in biotechnology, personalization of medicine approaches, innovative methods of drug delivery, regulatory consent, and creation of nerve growth factor (NGF) antibodies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22070&type=smp

What Market Forces Are Contributing To The Growth Of The Nerve Growth Factor Market?

The escalating occurrence of neurological ailments is anticipated to fuel the expansion of the nerve growth factor market in the future. These disorders, which affect the brain, spinal cord, and nerves, stem from structural, biochemical, or electrical irregularities. The rise in such conditions is attributed to an aging population and advancements in diagnostic technology. Enhanced diagnostic methods augment the identification and documentation of these disorders, leading to increased reported incidence rates. The nerve growth factor (NGF) has a vital part in the sustenance, survival, and regeneration of neurons, thus making it integral in addressing the increasing occurrence of neurological disorders by fostering neural repair and potentially decelerating the progress of the disease. For instance, the Australian Institute of Health and Welfare reported in September 2024 that dementia cases (a neurological disorder) in Australia are projected to surge from approximately 411,100 in 2023 to 849,300 by 2058. Consequently, the escalating occurrence of neurological conditions is catalyzing the expansion of the nerve growth factor market.

What Are The Main Segment Classifications In The Nerve Growth Factor Market?

The nerve growth factor market covered in this report is segmented –

1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types

2) By Agents: Cenegermin, Other Agents

3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Alpha-Nerve Growth Factor (a-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications

2) By Beta-Nerve Growth Factor (ß-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF

3) By Gamma-Nerve Growth Factor (?-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research

4) Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials

How Are Industry Trends Steering The Expansion Of The Nerve Growth Factor Market?

Top firms in the nerve growth factor industry are concentrating on the creation of sophisticated products like nerve growth factor (NGF) monoclonal antibodies to suppress NGF, with a goal of delivering effective pain relief. An NGF monoclonal antibody is a biological medication that zeroes in on and neutralizes NGF to prevent receptor interaction, therefore alleviating pain and decreasing nerve inflammation. It aids in the control of pain signals and the survival of nerve cells. For example, in February 2022, Akeso, Inc., a Chinese biopharmaceutical agency, launched AK115, a humanized IgG1 monoclonal antibody that was approved by China’s National Medical Products Administration to start clinical trials for treating pain, including that from cancer. AK115 is engineered to obstruct NGF’s interaction with receptors and aims to alleviate pain while ensuring long-term safety, non-addictiveness, and enhanced efficacy for patients with cancer who are resistant to opioids. The aim of this next-gen analgesic is to provide long-term, non-addictive pain relief, particularly for cancer patients resistant to opioids, thereby enhancing their quality of life.

Which Firms Are Driving Innovation Within The Nerve Growth Factor Market?

Major companies operating in the nerve growth factor market are Pfizer Inc., AstraZeneca Plc, Eli Lilly & Company, Teva Pharmaceutical Industries, Regeneron Pharmaceuticals Inc., Genetech, Dompé farmaceutici S.p.A., Promega Corporation, Akeso Inc, CUSABIO TECHNOLOGY LLC, Staidson Beijing BioPharmaceuticals, Biocare Medical LLC, Beike Biotechnology, Enzo Life Sciences Inc., Genexis Biotech Pvt. Ltd., Mimetogen Pharmaceuticals, Alomone Labs, MimeTech Srl, Herantis Pharma, Prospec-Tany Technogene Ltd., PainCeptor Pharma

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/nerve-growth-factor-global-market-report

What Are The Emerging Regional Trends Driving The Nerve Growth Factor Market?

Asia-Pacific was the largest region in the nerve growth factor market in 2024. The regions covered in the nerve growth factor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22070&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model